Castle Biosciences, Inc. - Common stock — Quarterly Cash Flow (NASDAQ:CSTL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 501.71 M544.73 M562.79 M578.56 M547.8 M Total liabilities 61.41 M89.35 M95.74 M107.68 M86.39 M Total equity 440.31 M455.38 M467.05 M470.87 M461.42 M Total liabilities & shareholders' equities 501.71 M544.73 M562.79 M578.56 M547.8 M Total debt 8.92 M8.1 M10.05 M9.64 M8.4 M Net debt 8.92 M8.1 M10.05 M9.64 M8.4 M

News

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales

Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know

CRISPR Therapeutics' Q1 Loss Wider Than Expected, Sales Miss Estimates

SMMT Q1 Loss Narrower Than Expected, Stock Down on Ivonescimab Setback